Search Results - "Schutz, Fabio A. B."

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer: A Meta-analysis of Randomized Trials by Nguyen, Paul L, Je, Youjin, Schutz, Fabio A. B, Hoffman, Karen E, Hu, Jim C, Parekh, Arti, Beckman, Joshua A, Choueiri, Toni K

“…CONTEXT Whether androgen deprivation therapy (ADT) causes excess cardiovascular deaths in men with prostate cancer is highly controversial and was the subject…”
Get full text

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials by Je, Youjin, MS, Schutz, Fabio AB, MD, Choueiri, Toni K, Dr

“…Summary Background Sunitinib and sorafenib are oral vascular endothelial growth factor receptor (VEGFR) tyrosine-kinase inhibitors used in various cancers…”
Get full text

Meta-Analysis of Randomized Controlled Trials for the Incidence and Risk of Treatment-Related Mortality in Patients With Cancer Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors by SCHUTZ, Fabio A. B, YOUJIN JE, RICHARDS, Christopher J, CHOUEIRI, Toni K

“…Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) have become the cornerstone in the treatment of several malignancies…”
Get full text

Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials by CHOUEIRI, Toni K, SCHUTZ, Fabio A. B, YOUJIN JE, ROSENBERG, Jonathan E, BELLMUNT, Joaquim

“…Sunitinib and sorafenib are oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) used in a vast range of cancers…”
Get full text

Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens by BELLMUNT, Joaquim, CHOUEIRI, Toni K, FOUGERAY, Ronan, SCHUTZ, Fabio A. B, SALHI, Yacine, WINQUIST, Eric, CULINE, Stéphane, VON DER MAASE, Hans, VAUGHN, David J, ROSENBERG, Jonathan E

“…PURPOSE The present study sought to identify pretreatment prognostic factors for overall survival (OS) in patients with metastatic transitional cell carcinoma…”
Get full text

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study by Schutz, Fabio AB, MD, Pomerantz, Mark M, MD, Gray, Kathryn P, PhD, Atkins, Michael B, Prof, Rosenberg, Jonathan E, MD, Hirsch, Michelle S, MD, McDermott, David F, MD, Lampron, Megan E, BS, Lee, Gwo-Shu Mary, MD, Signoretti, Sabina, MD, Kantoff, Philip W, Prof, Freedman, Matthew L, MD, Choueiri, Toni K, Dr

“…Summary Background Germline genetic polymorphisms might affect the risk of recurrence in patients with localised renal-cell carcinoma. We investigated the…”
Get full text

Haematologic toxicities associated with the addition of bevacizumab in cancer patients by Schutz, Fabio A.B, Jardim, Denis L.F, Je, Youjin, Choueiri, Toni K

“…Abstract Background Bevacizumab is currently approved for the treatment of several malignancies. Haematologic toxicities are not among the main concerns…”
Get full text

Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab by CHOUEIRI, Toni K, MAYER, Erica L, JE, Youjin, ROSENBERG, Jonathan E, NGUYEN, Paul L, AZZI, Georges R, BELLMUNT, Joaquim, BURSTEIN, Harold J, SCHUTZ, Fabio A. B

“…Bevacizumab is a treatment option in patients with metastatic breast cancer. Congestive heart failure (CHF) has been reported, although the overall incidence…”
Get full text

Pazopanib: Clinical development of a potent anti-angiogenic drug by Schutz, Fabio A.B, Choueiri, Toni K, Sternberg, Cora N

“…Abstract Pazopanib is an oral, multi-targeted, tyrosine kinase inhibitor (TKI) that binds to the vascular endothelial growth factor receptor (VEGFR),…”
Get full text

Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib by RICHARDS, Christopher J, YOUJIN JE, SCHUTZ, Fabio A. B, HENG, Daniel Y. C, DALLABRIDA, Susan M, MOSLEHI, Javid J, CHOUEIRI, Toni K

“…Sunitinib is a multitargeted receptor tyrosine kinase inhibitor approved for treatment of renal cell carcinoma (RCC) and GI stromal tumor. Congestive heart…”
Get full text

Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome by Dabydeen, Donnette A, Jagannathan, Jyothi P, Ramaiya, Nikhil, Krajewski, Katherine, Schutz, Fabio A.B, Cho, Daniel C, Pedrosa, Ivan, Choueiri, Toni K

“…Abstract Background Mammalian target of rapamycin (mTOR) inhibitors are approved for use in patients with metastatic renal cell carcinoma (mRCC) and are under…”
Get full text

The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium by Schutz, Fabio A.B, Xie, Wanling, Donskov, Frede, Sircar, Monica, McDermott, David F, Rini, Brian I, Agarwal, Neeraj, Pal, Sumanta Kumar, Srinivas, Sandy, Kollmannsberger, Christian, North, Scott A, Wood, Lori A, Vaishampayan, Ulka, Tan, Min-Han, Mackenzie, Mary J, Lee, Jae Lyun, Rha, Sun-Young, Yuasa, Takeshi, Heng, Daniel Y.C, Choueiri, Toni K

“…Abstract Background Hyponatremia has been associated with poor survival in many solid tumors and more recently found to be of prognostic and predictive value…”
Get full text

Thermal Ablation vs Surgery for Localized Kidney Cancer: a Surveillance, Epidemiology, and End Results (SEER) Database Analysis by Choueiri, Toni K, Schutz, Fabio A.B, Hevelone, Nathanael D, Nguyen, Paul L, Lipsitz, Stuart R, Williams, Stephen B, Silverman, Stuart G, Hu, Jim C

“…Objective To evaluate contemporary national practice pattern trends in the use of thermal ablation (radiofrequency ablation and cryoablation) in the management…”
Get full text

Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials by Schutz, Fabio A.B, Je, Youjin, Choueiri, Toni K

“…Abstract Background Sorafenib is a vascular endothelial growth factor receptor tyrosine-kinase inhibitor currently used in several malignancies. While not a…”
Get full text

Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor–Targeted Therapy in Patients With Advanced Renal Cell Carcinoma by Krajewski, Katherine M, Guo, Mengye, Van den Abbeele, Annick D, Yap, Jeffrey, Ramaiya, Nikhil, Jagannathan, Jyothi, Heng, Daniel Y.C, Atkins, Michael B, McDermott, David F, Schutz, Fabio A.B, Pedrosa, Ivan, Choueiri, Toni K

“…Abstract Background Vascular endothelial growth factor (VEGF)-targeted therapy has become standard treatment for patients with metastatic renal cell cancer…”
Get full text

Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine by Krajewski, Katherine M, Fougeray, Ronan, Bellmunt, Joaquim, Pons, Francesc, Schutz, Fabio A.B, Rosenberg, Jonathan E, Salhi, Yacine, Choueiri, Toni K

“…Abstract Background Vinflunine (VFL) has been approved in the European Union for second-line treatment of advanced transitional cell carcinoma of the…”
Get full text

Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid by Schutz, Fabio A B, Bellmunt, Joaquim, Rosenberg, Jonathan E, Choueiri, Toni K

“…Vinca alkaloid agents have been widely used in several different types of malignancies. However, cancer cells, ultimately, develop resistance to these agents…”
Get more information

Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma by RIESTER, Markus, WERNER, Lillian, CHOUEIRI, Toni K, SIGNORETTI, Sabina, LLORETA, Josep, MARCHIONNI, Luigi, GALLARDO, Enrique, ROJO, Federico, GARCIA, Denise I, CHEKALUK, Yvonne, KWIATKOWSKI, David J, BOCHNER, Bernard H, BELLMUNT, Joaquim, HAHN, William C, LIGON, Azra H, BARLETTA, Justine A, LODA, Massimo, BERMAN, David M, KANTOFF, Philip W, MICHOR, Franziska, ROSENBERG, Jonathan E, SELVARAJAH, Shamini, GUANCIAL, Elizabeth A, WEIR, Barbara A, STACK, Edward C, PARK, Rachel S, O'BRIEN, Robert, SCHUTZ, Fabio A. B

“…Metastatic urothelial carcinoma of the bladder is associated with multiple somatic copy-number alterations (SCNAs). We evaluated SCNAs to identify predictors…”
Get full text

Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review by Schmerling, Rafael A, Buzaid, Antonio C, Haddad, Carolina K, Schutz, Fabio Ab, Kater, Fabio R, Pimenta, Juliana, Maluf, Fernando, William, William N, Lopes, Camila, Bromberg, Dafne R, Oliveira, Ana C, Golmia, Ricardo, Scheinberg, Morton

“…The presence of autoimmune events were recorded in patients receiving immune checkpoint inhibitors. Retrospective study in patients receiving immune checkpoint…”
Get full text

Neoadjuvant and Adjuvant Therapies in Prostate Cancer by Schutz, Fabio A.B., MD, Oh, William K., MD

“…Prostate cancer is the most common cancer in men in the United States and the second leading cause of cancer death. Advances in surgical therapies have…”
Get full text